Stocks and Investing Stocks and Investing
Mon, April 19, 2021

Matthew Harrison Maintained (BIIB) at Buy with Decreased Target to $343 on, Apr 19th, 2021


Published on 2024-10-27 16:17:31 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $351 to $343 on, Apr 19th, 2021.

Matthew has made no other calls on BIIB in the last 4 months.



There are 5 other peers that have a rating on BIIB. Out of the 5 peers that are also analyzing BIIB, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $245 on, Monday, April 12th, 2021
  • Alethia Young of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $268 on, Wednesday, February 17th, 2021


These are the ratings of the 3 analyists that currently disagree with Matthew


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $305 on, Thursday, February 4th, 2021
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $338 on, Thursday, February 4th, 2021
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $380 on, Thursday, February 4th, 2021
Contributing Sources